🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Status
Withdrawn
Location
CHU de Clermont-Ferrand
Start Date
TBD
Trial ID
NCT02844530
Treatments Being Tested
Multicenter, randomized, open-label, parallel-group study of guadecitabine ...
Status
Completed
Location
University of Southern California
Start Date
2017-03-16
Trial ID
NCT02920008
Treatments Being Tested
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-11-22
Trial ID
NCT03926624
The goal of Phase 1b is to establish the safety of asciminib in combination...
Status
Not Yet Recruiting
Location
UT MD Anderson
Start Date
2026-11-30
Trial ID
NCT07604233
Treatments Being Tested
This protocol corresponds to a multicenter, open-label, non-randomized, pha...
Status
Completed
Location
Hospital Germans Tries i Pujol, Badalona
Start Date
2018-07-17
Trial ID
NCT03661515
Treatments Being Tested
The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Status
Unknown
Location
Aalborg University Hospital
Start Date
2014-10-30
Trial ID
NCT02272478
Association group of therapeutic specialities authorized in a remission ind...
Status
Completed
Location
Hospital de la Ribera
Start Date
1998-07
Trial ID
NCT00487448
This phase I trial studies the side effects and best dose of ivosidenib whe...
Status
Terminated
Location
Northwestern University
Start Date
2020-12-21
Trial ID
NCT04250051
Treatments Being Tested
This study is a multicenter, randomized, open-label, phase III clinical stu...
Status
Recruiting
Location
Anhui Provincial Hospital（The First Affiliated Hospital of U STC）
Start Date
2024-04-26
Trial ID
NCT06387069
Treatments Being Tested
The primary objective was to evaluate the effect of blinatumomab on overall...
Status
Terminated
Location
Research Site
Start Date
2014-01-03
Trial ID
NCT02013167
Treatments Being Tested